Search research articles
Contact Us
Filters
Showing results (451-460 of 625) with videos related to
Page
of 63
Sort By:
Obstetrics and Gynecology
|
January 8, 2026
Abnormal Uterine Bleeding Among Oral Anticoagulant Users
Lielle R Yellin, Yongmei Huang, Xiao Xu, et al.
Orthopaedic Journal of Sports Medicine
|
January 31, 2025
Evaluating Differences in Baseline Knee Hyperextension and Postoperative Stiffness Between Patients With Tibial Spine Fracture Versus ACL Tear
Patrick England, Joseph L Yellin, Michael V Carter, et al.
Journal of Pediatric Orthopedics
|
December 18, 2023
Patella and Trochlea Osteochondritis Dissecans: Demographics and Treatment Paradigms
Sara N Kiani, Joseph L Yellin, William H Huffman, et al.
Surgery, Gynecology & Obstetrics
|
January 1, 1986
Imipenem therapy for perforated and gangrenous appendicitis
P N Heseltine, A E Yellin, M D Appleman, et al.
Journal of the American College of Surgeons
|
April 1, 1994
Single-dose cefuroxime versus multiple-dose cefazolin as prophylactic therapy for high-risk cholecystectomy
K R Sirinek, P R Schauer, A E Yellin, et al.
Atherosclerosis
|
July 24, 2021
Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study
Matthew J Janik, Dorothea V Urbach, Elane van Nieuwenhuizen, et al.
Journal of Vascular Surgery
|
October 1, 1990
Surgical procedures in the management of Takayasu's arteritis
F A Weaver, A E Yellin, D H Campen, et al.
Injury
|
October 8, 2016
End-tidal CO<sub>2</sub> on admission is associated with hemorrhagic shock and predicts the need for massive transfusion as defined by the critical administration threshold: A pilot study
Melvin E Stone, Stanley Kalata, Anna Liveris, et al.
Plos One
|
April 2, 2024
Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort
Felipe Echeverri Tribin, Erin Williams, Valeska Testamarck, et al.
BMC Infectious Diseases
|
October 21, 2005
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]
María E Oliva, Arcot Rekha, Albert Yellin, et al.
Page
of 63
Search research articles
Search
Showing results (451-460 of 625) with videos related to
Sort By:
Page
of 63
Obstetrics and Gynecology
|
January 8, 2026
Abnormal Uterine Bleeding Among Oral Anticoagulant Users
Lielle R Yellin, Yongmei Huang, Xiao Xu, et al.
Orthopaedic Journal of Sports Medicine
|
January 31, 2025
Evaluating Differences in Baseline Knee Hyperextension and Postoperative Stiffness Between Patients With Tibial Spine Fracture Versus ACL Tear
Patrick England, Joseph L Yellin, Michael V Carter, et al.
Journal of Pediatric Orthopedics
|
December 18, 2023
Patella and Trochlea Osteochondritis Dissecans: Demographics and Treatment Paradigms
Sara N Kiani, Joseph L Yellin, William H Huffman, et al.
Surgery, Gynecology & Obstetrics
|
January 1, 1986
Imipenem therapy for perforated and gangrenous appendicitis
P N Heseltine, A E Yellin, M D Appleman, et al.
Journal of the American College of Surgeons
|
April 1, 1994
Single-dose cefuroxime versus multiple-dose cefazolin as prophylactic therapy for high-risk cholecystectomy
K R Sirinek, P R Schauer, A E Yellin, et al.
Atherosclerosis
|
July 24, 2021
Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study
Matthew J Janik, Dorothea V Urbach, Elane van Nieuwenhuizen, et al.
Journal of Vascular Surgery
|
October 1, 1990
Surgical procedures in the management of Takayasu's arteritis
F A Weaver, A E Yellin, D H Campen, et al.
Injury
|
October 8, 2016
End-tidal CO<sub>2</sub> on admission is associated with hemorrhagic shock and predicts the need for massive transfusion as defined by the critical administration threshold: A pilot study
Melvin E Stone, Stanley Kalata, Anna Liveris, et al.
Plos One
|
April 2, 2024
Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort
Felipe Echeverri Tribin, Erin Williams, Valeska Testamarck, et al.
BMC Infectious Diseases
|
October 21, 2005
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]
María E Oliva, Arcot Rekha, Albert Yellin, et al.
Page
of 63